Trexquant Investment LP Has $5.10 Million Stake in LifeStance Health Group, Inc. (NASDAQ:LFST)

Trexquant Investment LP increased its stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 111.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 692,037 shares of the company’s stock after purchasing an additional 364,990 shares during the quarter. Trexquant Investment LP owned approximately 0.18% of LifeStance Health Group worth $5,100,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in LFST. Geode Capital Management LLC boosted its stake in shares of LifeStance Health Group by 26.8% during the 3rd quarter. Geode Capital Management LLC now owns 3,452,178 shares of the company’s stock valued at $24,170,000 after buying an additional 729,794 shares during the period. Charles Schwab Investment Management Inc. boosted its position in LifeStance Health Group by 36.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,104,453 shares of the company’s stock valued at $7,731,000 after purchasing an additional 297,723 shares during the last quarter. SG Americas Securities LLC boosted its position in LifeStance Health Group by 65.7% during the fourth quarter. SG Americas Securities LLC now owns 90,355 shares of the company’s stock valued at $666,000 after purchasing an additional 35,823 shares during the last quarter. JPMorgan Chase & Co. grew its stake in LifeStance Health Group by 13.0% in the third quarter. JPMorgan Chase & Co. now owns 94,636 shares of the company’s stock valued at $662,000 after purchasing an additional 10,894 shares in the last quarter. Finally, Point72 Asset Management L.P. increased its position in LifeStance Health Group by 24.9% in the 3rd quarter. Point72 Asset Management L.P. now owns 1,100,441 shares of the company’s stock worth $7,703,000 after purchasing an additional 219,329 shares during the last quarter. 85.50% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on LFST shares. William Blair reiterated an “outperform” rating on shares of LifeStance Health Group in a report on Friday, February 28th. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price for the company in a research note on Monday, December 16th. Finally, Canaccord Genuity Group started coverage on shares of LifeStance Health Group in a report on Thursday. They set a “buy” rating and a $8.00 price target on the stock. One investment analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, LifeStance Health Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $8.50.

Insider Activity

In related news, insider Lisa K. Miller sold 18,845 shares of LifeStance Health Group stock in a transaction on Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the transaction, the insider now owns 339,810 shares in the company, valued at $2,344,689. This trade represents a 5.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 6.60% of the company’s stock.

LifeStance Health Group Stock Down 1.5 %

LFST opened at $6.64 on Friday. The firm has a market cap of $2.55 billion, a P/E ratio of -25.54 and a beta of 1.30. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32. The business has a 50 day moving average price of $7.47 and a 200 day moving average price of $7.34. LifeStance Health Group, Inc. has a twelve month low of $4.64 and a twelve month high of $8.61.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.